251 results on '"Ticchioni, Michel"'
Search Results
2. Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis
3. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
4. Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial
5. Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
6. Supplementary Figure 1 from Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
7. Data from Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
8. Supplementary Table 1 from Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
9. Supplementary Figures 5-6 from Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
10. Supplementary Figure 2 from Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
11. Supplementary Methods, Legends for Table, Figures 1-6 from Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
12. Supplementary Figures 3-4 from Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
13. Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
14. HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)
15. Laminin 5 in the Human Thymus: Control of T Cell Proliferation via α 6 β 4 Integrins
16. Endocytosis of GPI-Anchored Proteins in Human Lymphocytes: Role of Glycolipid-Based Domains, Actin Cytoskeleton, and Protein Kinases
17. A Fixed-Duration Immunochemotherapy Approach Combined with Ibrutinib in CLL Produces Deep and Sustained MRD Responses: 5.5-Year Results from the Icll-07 Filo Trial
18. Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
19. Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
20. The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells
21. Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
22. Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation?
23. A fixed-duration, measurable residual disease–guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial
24. Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study
25. Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
26. Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
27. Idiopathic CD4 T Cell Lymphocytopenia: A Case of Overexpression of PD-1/PDL-1 and CTLA-4
28. Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia
29. New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia
30. Maintenance of Long-Term Undetectable Minimal Residual Disease after Combination of Ibrutinib with Abbreviated Chemotherapy in the Icll-07 Filo Trial
31. Phenotyping of Intrahepatic and Peripheral Blood Lymphocytes in Patients with Chronic Hepatitis C
32. Molecular Allelokaryotyping of Early-Stage, Untreated Chronic Lymphocytic Leukemia
33. Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions
34. Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow
35. Persistent viral load in patients on HAART is associated with a higher level of activation-induced apoptosis of CD4+ T cells
36. Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow
37. Laminin 5 in the Human Thymus: Control of T Cell Proliferation via α6β4 Integrins
38. The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review
39. Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience
40. High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
41. Le suivi des sous-populations des lymphocytes B par cytométrie de flux conditionne l’administration du Rituximab (RTX) dans la myasthénie généralisée (MG)
42. High Rate of Complete Response (CR) with Undetectable Bone Marrow Minimal Residual Disease (MRD) after Chemo-Sparing and MRD-Driven Strategy for Untreated Fit CLL Patients: Final Results of the Icll 07 Filo Trial
43. Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
44. Determination of acceptable limits of precision parameters for lymphocyte count by flow cytometry
45. Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration
46. Phenotyping of Intrahepatic and Peripheral Blood Lymphocytes in Patients with Chronic Hepatitis C
47. Erratum to ‘HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)’
48. Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia
49. Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis
50. Acceptable "Real‐Life" Variability for Lymphocyte Counts by Flow Cytometry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.